Related references
Note: Only part of the references are listed.Analysis of the genetic variability of PvMSP-3α among Plasmodium vivax in Brazilian field isolates
Ricardo Souza Ribeiro et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2011)
Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations
Faviel F. Gonzalez-Galarza et al.
NUCLEIC ACIDS RESEARCH (2011)
HLA DNA Sequence Variation among Human Populations: Molecular Signatures of Demographic and Selective Events
Stephane Buhler et al.
PLOS ONE (2011)
A Malaria Vaccine Based on the Polymorphic Block 2 Region of MSP-1 that Elicits a Broad Serotype-Spanning Immune Response
Graeme J. M. Cowan et al.
PLOS ONE (2011)
Evaluation of the genetic diversity of domain II of Plasmodium vivax Apical Membrane Antigen 1 (PvAMA-1) and the ensuing strain-specific immune responses in patients from Sri Lanka
Sajani Dias et al.
VACCINE (2011)
Malaria vaccine development based on merozoite surface proteins of Plasmodium falciparum
Virander S. Chauhan et al.
HUMAN VACCINES (2010)
HLA-DP, HLA-DQ, and HLA-DR Have Different Requirements for Invariant Chain and HLA-DM
Marcel van Lith et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Malaria in Brazil: an overview
Joseli Oliveira-Ferreira et al.
MALARIA JOURNAL (2010)
Promiscuous T-cell epitopes of Plasmodium merozoite surface protein 9 (PvMSP9) induces IFN-γ and IL-4 responses in individuals naturally exposed to malaria in the Brazilian Amazon
J. C. Lima-Junior et al.
VACCINE (2010)
The Relationship between Anti-merozoite Antibodies and Incidence of Plasmodium falciparum Malaria: A Systematic Review and Meta-analysis
Freya J. I. Fowkes et al.
PLOS MEDICINE (2010)
Acquired Immunity to Malaria
Denise L. Doolan et al.
CLINICAL MICROBIOLOGY REVIEWS (2009)
HLA-DR: Molecular Insights and Vaccine Design
Lawrence J. Stern et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Influence of HLA-DRB1 Alleles on Antibody Responses to PfCP-2.9-Immunized and Naturally Infected Individuals
Qingfeng Zhang et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2009)
Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite
Ivo Mueller et al.
LANCET INFECTIOUS DISEASES (2009)
Antibody responses to a panel of Plasmodium falciparum malaria blood-stage antigens in relation to clinical disease outcome in Sudan
Nnaemeka C. Iriemenam et al.
VACCINE (2009)
Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria
Faith H. A. Osier et al.
INFECTION AND IMMUNITY (2008)
Evaluation of the genetic polymorphism of Plasmodium falciparum P126 protein (SERA or SERP) and its influence on naturally acquired specific antibody responses in malaria-infected individuals living in the Brazilian Amazon
Lilian Rose Pratt-Riccio et al.
MALARIA JOURNAL (2008)
Plasmodium vivax: who cares?
Mary R. Galinski et al.
MALARIA JOURNAL (2008)
Naturally acquired humoral and cellular immune responses to Plasmodium vivax merozoite surface protein 9 in Northwestern Amazon individuals
J. C. Lima-Junior et al.
VACCINE (2008)
Antigenic polymorphism and naturally acquired antibodies to Plasmodium vivax merozoite surface protein 1 in rural Amazonians
Melissa S. Bastos et al.
CLINICAL AND VACCINE IMMUNOLOGY (2007)
Invasion of host cells by malaria parasites:: a tale of two protein families
Jayasree Iyer et al.
MOLECULAR MICROBIOLOGY (2007)
An update on the search for a Plasmodium vivax vaccine
Socrates Herrera et al.
TRENDS IN PARASITOLOGY (2007)
Human leukocyte antigen class II alleles influence levels of antibodies to the Plasmodium falciparum asexual-stage apical membrane antigen 1 but not to merozoite surface antigen 2 and merozoite surface protein 1
AH Johnson et al.
INFECTION AND IMMUNITY (2004)
HLA class II and antibody responses to circumsporozoite protein repeats of P-vivax (VK210, VK247 and P-vivax-like) in individuals naturally exposed to malaria
J Oliveira-Ferreira et al.
ACTA TROPICA (2004)
Malaria
KN Suh et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2004)
Immunogenicity of Plasmodium vivax merozoite surface protein-9 recombinant proteins expressed in E. coli
J Oliveira-Ferreira et al.
VACCINE (2004)
Human leukocyte antigen class II control of the immune response to p126-derived amino terminal peptide from Plasmodium falciparum
DM Banic et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2002)
Immunogenic properties of the Plasmodium vivax vaccine candidate MSP1(19) expressed as a secreted non-glycosylated polypeptide from Pichia pastoris
IS Soares et al.
PARASITOLOGY (2002)
Merozoite surface protein-9 of Plasmodium vivax and related simian malaria parasites is orthologous to p101/ABRA of P-falciparum
E Vargas-Serrato et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2002)
Comparison of the immunogenic properties of recombinant proteins representing the Plasmodium vivax vaccine candidate MSP119 expressed in distinct bacterial vectors
MG Cunha et al.
VACCINE (2001)
Family-based association of HLA class II alleles and haplotypes with type I diabetes in Brazilians reveals some characteristics of a highly diversified population
WMG Volpini et al.
HUMAN IMMUNOLOGY (2001)
Plasmodium vivax merozoite surface proteins-3β and-3γ share structural similarities with P. vivax merozoite surface protein-3α and define a new gene family
MR Galinski et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2001)
Interaction of HLA and age on levels of antibody to Plasmodium falciparum rhoptry-associated proteins 1 and 2
A Johnson et al.
INFECTION AND IMMUNITY (2000)
Share Paper
